# lenalidomide

NDC: 69097-385
Generic name: lenalidomide
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20220906

FDA application: ANDA210435

## Active ingredients

- LENALIDOMIDE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-385"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-385
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba2a07fd-ca60-40bc-b79b-9caf81900fa3